The global anticoagulants market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Anticoagulants are the kinds of chemical substances delivered in the form of drugs that act as blood thinners. These basically prevent or reduce coagulation of blood by prolonging the time for blood clotting. Anticoagulants find their application in the treatment of various medical conditions, which primarily include stroke, myocardial infarction, deep vein thrombosis, pulmonary embolism, and others. Adding to this, as per the National Center for Biotechnology Information (NCBI), in 2018, nearly 1 in 3 of all adults suffered from multiple chronic conditions all over the globe. Thus, the growing prevalence of chronic disorders such as chronic kidney disease and hypertension are likely to boost the demand for anticoagulants.  

Some key players operating in the market include Johnson & Johnson Services, Inc., Bristol-Myers Squibb Co., and Bayer AG, among others. The market players are eyeing on strengthening their position in the market and therefore, focusing on the adoption of various strategies as mergers and acquisitions, partnerships, collaborations, new product launches and development in the existing product portfolio, and so on. For instance, in December 2020, Nacto Pharma launched a Rivaroxban molecule under the brand name RPIGAT. Rivaroxban is an anticoagulant medication used to prevent blood clots. 

Market Coverage

    • The market number available for – 2020-2027

    • Base year- 2020

    • Forecast period- 2021-2027

    • Segment Covered- 

o By Drug Class

o By Route of Administration

o By Application

• Regions covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

    • Competitive Landscape:  Johnson & Johnson Services, Inc., Bristol-Myers Squibb Co., and Bayer AG, among others.

Key questions addressed by the report

    • What is the market growth rate?

    • Which segment and region dominate the market in the base year?

    • Which segment and region will project the fastest growth in the market?

    • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

    • Who is the leader in the market?

    • How are players addressing challenges to sustain growth?

    • Where is the investment opportunity?

Global Anticoagulants Market Report by Segment

By Drug Class

    • NOACs

    • Heparin & LMWH

    • Vitamin K Antagonist

By Route of Administration

    • Oral Anticoagulant

    • Injectable Anticoagulant

By Application

    • Atrial Fibrillation & Heart Attack 

    • Stroke

    • Deep Vein Thrombosis (DVT)

    • Pulmonary Embolism

    • Others

Global Anticoagulants Market Report by Region

North America       

    • US

    • Canada

Europe

    • Germany

    • UK

    • France

    • Spain

    • Italy

    • Rest of Europe

Asia-Pacific    

    • China

    • Japan

    • India

    • Rest of Asia-Pacific

Rest of the World

    • Latin America

    • Middle East and Africa